Filter

881 - 890 of 2,163 Results

  • Current Status of the Title X Network and the Path Forward

    Interactive

    This issue brief presented in a narrative story map reviews the impact the Trump Administration regulations have had on the Title X network and discusses the likely impact and limitations of the Biden Administration’s potential actions.

  • Medicaid Maintenance of Eligibility (MOE) Requirements: Issues to Watch

    Issue Brief

    Federal legislation provides a temporary increase in federal Medicaid matching rates to states conditioned on states providing continuous eligibility for existing enrollees and meeting certain other eligibility requirements. This brief provides an overview of these maintenance of eligibility (MOE) requirements, examines what happens when the MOE expires, and discusses key issues to consider looking ahead.

  • Health Insurer Financial Performance Through September 2020

    Issue Brief

    In this brief, we analyze third quarter data from 2018 to 2020 to examine how insurance markets performed financially through the end of September. Average margins remained relatively high compared to the same point in recent years, suggesting many insurers remained profitable even as non-COVID-related care returned in the summer and fall.

  • Coronavirus Puts a Spotlight on Paid Leave Policies

    Issue Brief

    As the COVID-19 pandemic grows, the Centers for Disease Control and Prevention (CDC) and other public health officials recommend that people who are sick should stay home. Benefits such as sick leave and family leave can help employees follow these guidelines; however, the U.S. does not have national standards on paid family or sick leave. The lack of a national policy means some employees are forced to take unpaid leave, or come to work when…

  • Who Didn’t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines

    Issue Brief

    As the U.S. prepares for nationwide distribution of vaccines to combat COVID-19, some are asking whether people who get the first of two doses will return to complete the series. This analysis draws on Medicare Part D prescription drug claims data for the herpes zoster vaccine Shingrix, which also requires two doses, to shed light on this potential challenge of the leading COVID-19 vaccine candidates.

  • Estimates of the Initial Priority Population for COVID-19 Vaccination by State

    Issue Brief

    This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.